BR0316687A - Composição e adjuvante vacinal e método para a obtenção de estruturas cocleares a partir de vesìculas de membrana externa de organismos vivos - Google Patents

Composição e adjuvante vacinal e método para a obtenção de estruturas cocleares a partir de vesìculas de membrana externa de organismos vivos

Info

Publication number
BR0316687A
BR0316687A BR0316687-2A BR0316687A BR0316687A BR 0316687 A BR0316687 A BR 0316687A BR 0316687 A BR0316687 A BR 0316687A BR 0316687 A BR0316687 A BR 0316687A
Authority
BR
Brazil
Prior art keywords
membrane vesicles
adjuvant
living organisms
obtaining
outer membrane
Prior art date
Application number
BR0316687-2A
Other languages
English (en)
Inventor
Gustavo Rafael Bracho Granado
Concepcion Campa Huergo
Nestor Mora Gonzalez
Ramon Faustino Barbera Morales
Judit Monica Del Campo Alonso
Tamara Rodriguez Ramirez
Caridad Zayas Vignier
Danay Gil Martinez
Carlos Taboada Suarez
Oliver German Perez Martin
Miriam De San Juan Bo Gonzalez
Victoriano Gustavo Si Gonzalez
Original Assignee
Inst Finlay Ct De Investigacio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Finlay Ct De Investigacio filed Critical Inst Finlay Ct De Investigacio
Publication of BR0316687A publication Critical patent/BR0316687A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/008—Leishmania antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Otolaryngology (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

"COMPOSIçãO E ADJUVANTE VACINAL E MéTODO PARA A OBTENçãO DE ESTRUTURAS COCLEARES A PARTIR DE VESìCULAS DE MEMBRANA EXTERNA DE ORGANISMOS VIVOS". A presente invenção refere-se ao campo da imunologia, particularmente ao ramo referente aos adjuvantes e às vacinas. O objetivo técnico perseguido é o de obter estruturas cocleares a partir de vesículas de membrana externa (ampolas) de microorganismos, com o fim de empregá-las como adjuvantes ou como vacinas propriamente ditas. A invenção também se refere ao método de obtenção das estruturas cocleares.
BR0316687-2A 2002-11-27 2003-11-27 Composição e adjuvante vacinal e método para a obtenção de estruturas cocleares a partir de vesìculas de membrana externa de organismos vivos BR0316687A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20020292A CU23313A1 (es) 2002-11-27 2002-11-27 Mã0/00todo de obtenciã"n de estructuras cocleares. composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios
PCT/CU2003/000016 WO2004047805A1 (es) 2002-11-27 2003-11-27 Obtencion de estructuras cocleares, composiciones vacunales, adyuvantes y sus intermediarios.

Publications (1)

Publication Number Publication Date
BR0316687A true BR0316687A (pt) 2005-10-18

Family

ID=40122451

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0316687-2A BR0316687A (pt) 2002-11-27 2003-11-27 Composição e adjuvante vacinal e método para a obtenção de estruturas cocleares a partir de vesìculas de membrana externa de organismos vivos

Country Status (13)

Country Link
US (1) US20060134134A1 (pt)
EP (2) EP1602360B1 (pt)
CN (1) CN1744883B (pt)
AR (1) AR042237A1 (pt)
AT (1) ATE530166T1 (pt)
AU (1) AU2003281911A1 (pt)
BR (1) BR0316687A (pt)
CA (1) CA2518906A1 (pt)
CU (1) CU23313A1 (pt)
DK (1) DK1602360T3 (pt)
ES (1) ES2376227T3 (pt)
WO (1) WO2004047805A1 (pt)
ZA (1) ZA200504729B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009049013A2 (en) * 2007-10-09 2009-04-16 Tufts University Cholera vaccines
CU20080215A7 (es) 2008-11-19 2012-06-21 Inst Finlay Vacunas unitemporales
WO2011027956A2 (ko) 2009-09-04 2011-03-10 주식회사이언메딕스 그람 양성 박테리아에서 유래한 세포밖 소포체 및 이를 이용한 질병 모델
CU20100083A7 (es) 2010-05-05 2012-06-21 Inst Finlay Tolerogenos adyuvados como vacuna de malaria
CU20110202A7 (es) * 2011-11-02 2013-12-27 Inst Finlay Ct De Investigación Producción De Sueros Y Vacunas Composición inmunogénica de polisacáridos planos adyuvados y las formulaciones resultantes
EP2689775A1 (en) * 2012-07-25 2014-01-29 Instituto Finlay, Centro de Investigacion-Produccion de vacunas y sueros Cochleate with only one mamp
WO2021031270A1 (zh) * 2019-08-22 2021-02-25 四川大学 细菌膜囊泡及其分离制备系统和方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US597572A (en) * 1898-01-18 Indicator for oil-wells
CH588887A5 (pt) 1974-07-19 1977-06-15 Battelle Memorial Institute
GB1578776A (en) 1976-06-10 1980-11-12 Univ Illinois Hemoglobin liposome and method of making the same
GB2026340B (en) 1978-07-03 1982-12-22 Ash P Stabilising microvesicles
DE2848965A1 (de) 1978-11-11 1980-05-22 Behringwerke Ag Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine
US4271147A (en) 1980-01-10 1981-06-02 Behringwerke Aktiengesellschaft Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same
US4663161A (en) 1985-04-22 1987-05-05 Mannino Raphael J Liposome methods and compositions
JPH01125328A (ja) 1987-07-30 1989-05-17 Centro Natl De Biopreparados 髄膜炎菌ワクチン
WO1993014744A1 (en) * 1992-02-04 1993-08-05 Chiron Corporation Non-toxic lipid vaccine formulations
US5643574A (en) 1993-10-04 1997-07-01 Albany Medical College Protein- or peptide-cochleate vaccines and methods of immunizing using the same
US5994318A (en) * 1993-10-04 1999-11-30 Albany Medical College Cochleate delivery vehicles
US5851536A (en) 1995-11-22 1998-12-22 University Of Washington Therapeutic delivery using compounds self-assembled into high axial ratio microstructures
US5834015A (en) * 1996-09-11 1998-11-10 Albany Medical College Protein-lipid vesicles and autogenous vaccine comprising the same
US6180114B1 (en) 1996-11-21 2001-01-30 University Of Washington Therapeutic delivery using compounds self-assembled into high axial ratio microstructures
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
NO20002828D0 (no) * 2000-06-02 2000-06-02 Statens Inst For Folkehelse Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav
GB0103170D0 (en) * 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition

Also Published As

Publication number Publication date
HK1088827A1 (en) 2006-11-17
US20060134134A1 (en) 2006-06-22
WO2004047805A1 (es) 2004-06-10
ATE530166T1 (de) 2011-11-15
DK1602360T3 (da) 2012-02-13
CU23313A1 (es) 2008-09-25
AU2003281911A1 (en) 2004-06-18
CN1744883B (zh) 2011-06-08
AR042237A1 (es) 2005-06-15
CA2518906A1 (en) 2004-06-10
EP1602360B1 (en) 2011-10-26
EP1602360A1 (en) 2005-12-07
ES2376227T3 (es) 2012-03-12
ZA200504729B (en) 2006-09-27
EP2347764A2 (en) 2011-07-27
EP2347764A3 (en) 2011-10-26
CN1744883A (zh) 2006-03-08

Similar Documents

Publication Publication Date Title
AR061333A1 (es) Composiciones de vacuna de la neisseria
BR112012022688A2 (pt) proteína de fusão, vesícula da membrana externa isolada, polinucleotídeo, composição farmacêutica, vacina, método para tratamento ou prevenção de infecção ou doença por neisseria, uso e método para fabricar uma proteína de fusão
ES2139553T1 (es) Replicacion de virus de la gripe en un cultivo de celulas de mamiferos y produccion de vacuna.
BR112012022800A2 (pt) composição imunogênica ou vacina, cepa bacteriana gram-negativa geneticamente engenheirada, métodos para o tratamento ou prevenção de infecção ou doença, para produzir uma composição imunogênica ou uma vacina, e para preparar uma imunoglobulina, preparação da imunoglobulina, e, preparação farmacêutica
BR0015961A (pt) Antìgeno de neisseria de 85kda
EA200401383A1 (ru) Применение определённых алкоксилатов спиртов в качестве адъюванта в области агротехники
NO20091022L (no) Vaksine omfattende en olje i vann emulsjons-adjuvant
WO2002009746A8 (en) Vaccines comprising outer membrane vesciles from gram negative bacteria
PH12019500108A1 (en) Ultraportable system for intra-operative isolation and regulation of surgical site environments
BR0312362A (pt) Sola a prova d'água e respirável para calçados, uso de adesivos termorreativos, e, método para produzir uma sola a prova d'água e respirável para calçados
BRPI0410341A (pt) conjugados de polissacarìdeo-proteìna derivatizados de meningococos multivalente e vacina
CL2008003202A1 (es) Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta.
CL2023001142A1 (es) Composiciones y métodos para la vacunación contra neisseria gonorrhoeae
PT1112747E (pt) Vacina de salmonella que nao induz anticorpos contra flagelina ou flagelos
MX2010003220A (es) Proteinas inmunogenicas de membrana exterior derivada de genoma de leptospira y composiciones y metodos basados en las mismas.
RU2008144180A (ru) Вакцина против микоплазмы и prrsv
MX2023002786A (es) Vesículas de membrana exterior.
CU23313A1 (es) Mã0/00todo de obtenciã"n de estructuras cocleares. composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios
NZ580603A (en) Intradermal influenza vaccine
BR112013010338A2 (pt) composição, métodos para preparar uma composição imunogênica, para adjuvantar uma resposta imune, para eliciar uma resposta imune contra um agente infeccioso, para evitar e/ou reduzir a deposição de amilóide ou doença de alzheimer em um indivíduo, e para tratar/reduzir/melhorar a infecção por uma agente infeccioso, uso de uma proteína, e, kit
NZ591738A (en) Non-typhoidal salmonella vaccines comprising a polypeptide which is an outer membrane protein d of non typoidal salmonella
BRPI0510882A (pt) epìtopes lipopolisacarìdeos de núcleo interno conservado como candidatos de espécie de vacina: epìtopes lipopolisacarìdeos de núcleo interno como candidatos de vacina para a prevenção de doenças causadas por patogêneses bacterianas veterinárias incluindo actinobacillus pleuropneumoniae, mannheimia haemolytica e pasteurella multocida
CU23377A1 (es) Metodo para la incorporacion de antigenos en vesiculas de membrana externa de bacterias y formulaciones resultantes
MX2023000097A (es) Adyuvantes de vacunas y metodos de sintetizacion y uso de estos.
UY28207A1 (es) Composiciones vacunales a base de gangliósidos para administración subcutánea.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.